On February 10, 2026, Gilead Sciences, Inc. reported its financial results for the quarter and year ending December 31, 2025, revealing key insights based on both GAAP and non-GAAP measures. This event is classified under ‘Quarterly Earnings Reports’ and is considered significant for investors with a neutral sentiment.